IBDEI0LJ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9688,1,4,0)
 ;;=4^N64.4
 ;;^UTILITY(U,$J,358.3,9688,2)
 ;;=^5015794
 ;;^UTILITY(U,$J,358.3,9689,0)
 ;;=N64.51^^39^417^60
 ;;^UTILITY(U,$J,358.3,9689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9689,1,3,0)
 ;;=3^Induration of Breast
 ;;^UTILITY(U,$J,358.3,9689,1,4,0)
 ;;=4^N64.51
 ;;^UTILITY(U,$J,358.3,9689,2)
 ;;=^5015795
 ;;^UTILITY(U,$J,358.3,9690,0)
 ;;=N64.59^^39^417^105
 ;;^UTILITY(U,$J,358.3,9690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9690,1,3,0)
 ;;=3^Signs and Symptoms in Breast,Other
 ;;^UTILITY(U,$J,358.3,9690,1,4,0)
 ;;=4^N64.59
 ;;^UTILITY(U,$J,358.3,9690,2)
 ;;=^5015797
 ;;^UTILITY(U,$J,358.3,9691,0)
 ;;=N64.52^^39^417^71
 ;;^UTILITY(U,$J,358.3,9691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9691,1,3,0)
 ;;=3^Nipple Discharge
 ;;^UTILITY(U,$J,358.3,9691,1,4,0)
 ;;=4^N64.52
 ;;^UTILITY(U,$J,358.3,9691,2)
 ;;=^259531
 ;;^UTILITY(U,$J,358.3,9692,0)
 ;;=N64.53^^39^417^99
 ;;^UTILITY(U,$J,358.3,9692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9692,1,3,0)
 ;;=3^Retraction of Nipple
 ;;^UTILITY(U,$J,358.3,9692,1,4,0)
 ;;=4^N64.53
 ;;^UTILITY(U,$J,358.3,9692,2)
 ;;=^5015796
 ;;^UTILITY(U,$J,358.3,9693,0)
 ;;=N75.1^^39^417^8
 ;;^UTILITY(U,$J,358.3,9693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9693,1,3,0)
 ;;=3^Abscess of Bartholin's Gland
 ;;^UTILITY(U,$J,358.3,9693,1,4,0)
 ;;=4^N75.1
 ;;^UTILITY(U,$J,358.3,9693,2)
 ;;=^5015823
 ;;^UTILITY(U,$J,358.3,9694,0)
 ;;=N80.9^^39^417^37
 ;;^UTILITY(U,$J,358.3,9694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9694,1,3,0)
 ;;=3^Endometriosis,Unspec
 ;;^UTILITY(U,$J,358.3,9694,1,4,0)
 ;;=4^N80.9
 ;;^UTILITY(U,$J,358.3,9694,2)
 ;;=^5015837
 ;;^UTILITY(U,$J,358.3,9695,0)
 ;;=N81.4^^39^417^112
 ;;^UTILITY(U,$J,358.3,9695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9695,1,3,0)
 ;;=3^Uterovaginal Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,9695,1,4,0)
 ;;=4^N81.4
 ;;^UTILITY(U,$J,358.3,9695,2)
 ;;=^5015841
 ;;^UTILITY(U,$J,358.3,9696,0)
 ;;=N84.8^^39^417^87
 ;;^UTILITY(U,$J,358.3,9696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9696,1,3,0)
 ;;=3^Polyp of Other Parts of Female Genital Tract
 ;;^UTILITY(U,$J,358.3,9696,1,4,0)
 ;;=4^N84.8
 ;;^UTILITY(U,$J,358.3,9696,2)
 ;;=^5015868
 ;;^UTILITY(U,$J,358.3,9697,0)
 ;;=N84.0^^39^417^85
 ;;^UTILITY(U,$J,358.3,9697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9697,1,3,0)
 ;;=3^Polyp of Corpus Uteri
 ;;^UTILITY(U,$J,358.3,9697,1,4,0)
 ;;=4^N84.0
 ;;^UTILITY(U,$J,358.3,9697,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,9698,0)
 ;;=N84.9^^39^417^86
 ;;^UTILITY(U,$J,358.3,9698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9698,1,3,0)
 ;;=3^Polyp of Female Genital Tract,Unspec
 ;;^UTILITY(U,$J,358.3,9698,1,4,0)
 ;;=4^N84.9
 ;;^UTILITY(U,$J,358.3,9698,2)
 ;;=^5015869
 ;;^UTILITY(U,$J,358.3,9699,0)
 ;;=N84.1^^39^417^84
 ;;^UTILITY(U,$J,358.3,9699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9699,1,3,0)
 ;;=3^Polyp of Cervix Uteri
 ;;^UTILITY(U,$J,358.3,9699,1,4,0)
 ;;=4^N84.1
 ;;^UTILITY(U,$J,358.3,9699,2)
 ;;=^5015866
 ;;^UTILITY(U,$J,358.3,9700,0)
 ;;=N89.1^^39^417^114
 ;;^UTILITY(U,$J,358.3,9700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9700,1,3,0)
 ;;=3^Vaginal Dysplasia,Moderate
 ;;^UTILITY(U,$J,358.3,9700,1,4,0)
 ;;=4^N89.1
 ;;^UTILITY(U,$J,358.3,9700,2)
 ;;=^5015886
 ;;^UTILITY(U,$J,358.3,9701,0)
 ;;=N89.0^^39^417^113
 ;;^UTILITY(U,$J,358.3,9701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9701,1,3,0)
 ;;=3^Vaginal Dysplasia,Mild
